Cohn Peter F
Department of Medicine, Stony Brook University, Health Sciences Center, Stony Brook, NY 11794-8167, USA.
Prog Cardiovasc Dis. 2006 Sep-Oct;49(2):88-97. doi: 10.1016/j.pcad.2006.04.001.
The treatment of refractory chronic angina pectoris presents an increasing problem for all physicians caring for patients with coronary artery disease because of the large number of individuals who have either failed multiple revascularization procedures or are not appropriate candidates for such procedures. The aim of this study was to review the safety, efficacy, and clinical applicability of a noninvasive technique (external counterpulsation) for the treatment of angina pectoris. A MEDLINE search for all English language abstracts, meeting presentations, journal articles, and reviews from 1960 through December 2005 was conducted. Of the 194 citations in the literature, 60 appeared before 1983 when the enhanced version of the technique (the one that is presently used) was first reported. Criteria for further evaluation of the 134 post-1983 citations were either (1) randomized trial, (2) observational study of at least 10 patients, or (3) investigations into possible mechanisms. Of the 134 citations, 45 were used for data extraction. Observational studies from the United States, Asia, and Europe have demonstrated improvement in symptoms, reduction in anginal episodes, better quality of life, and improved exercise performance in over 5000 patients. The only randomized study (Multicenter Study of Enhanced External Counterpulsation) confirmed these findings as well as the continuation of clinical benefits at least 1 year posttreatment. Although the mechanisms by which diastolic augmentation achieves these beneficial results are still under investigation, this is a promising noninvasive therapy in a group of patients with limited treatment options.
对于所有治疗冠心病患者的医生而言,难治性慢性心绞痛的治疗正成为一个日益棘手的问题,因为有大量患者要么多次血运重建手术失败,要么不适合进行此类手术。本研究的目的是回顾一种用于治疗心绞痛的非侵入性技术(体外反搏)的安全性、有效性及临床适用性。我们对1960年至2005年12月期间的所有英文摘要、会议报告、期刊文章及综述进行了MEDLINE检索。文献中的194条引用中,有60条出现在1983年之前,当时该技术的改进版本(即目前使用的版本)首次被报道。对1983年之后的134条引用进行进一步评估的标准为:(1)随机试验;(2)对至少10名患者的观察性研究;或(3)对可能机制的研究。在这134条引用中,45条被用于数据提取。来自美国、亚洲和欧洲的观察性研究表明,5000多名患者的症状得到改善、心绞痛发作次数减少、生活质量提高且运动能力增强。唯一的随机研究(增强型体外反搏多中心研究)证实了这些发现,以及治疗后至少1年临床益处的持续存在。尽管舒张期增压实现这些有益效果的机制仍在研究中,但在治疗选择有限的一组患者中,这是一种有前景的非侵入性疗法。